Associated Papers
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK et al.
Oncogene, 2017
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
Goh G et al.
Plos Medicine, 2016
Select a paper to view details